SAREPTA - Trademark Details
Status: 700 - Registered
Serial Number
88514961
Registration Number
6342349
Word Mark
SAREPTA
Status
700 - Registered
Status Date
2021-05-04
Filing Date
2019-07-15
Registration Number
6342349
Registration Date
2021-05-04
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2020-02-25
Attorney Name
Law Office Assigned Location Code
L40
Employee Name
FATHY, DOMINIC
Statements
Goods and Services
Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Gene therapy products, namely, gene delivery pharmaceuticals; Pharmaceutical preparations for gene therapy, gene editing, and genome editing; Gene therapies for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Viruses, viral vectors and viral constructs for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases
Goods and Services
Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform; Pharmaceutical preparations that modulate RNA expression; Gene therapy products, namely, gene delivery pharmaceuticals; Pharmaceutical preparations for gene therapy, gene editing, and genome editing; Gene therapies for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Viruses, viral vectors and viral constructs for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations, biological preparations and gene therapy products for the treatment of genetic disorders and diseases
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
005, 006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2019-07-18
Primary Code
005
First Use Anywhere Date
2012-07-12
First Use In Commerce Date
2014-10-15
Current Trademark Owners
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Paul C. Llewellyn
Address
Please log in with your Justia account to see this address.
Prior Registrations
| Relationship Type | Reel Number |
| Prior Registration | 4653264 |
| Prior Registration | 4724239 |
| Prior Registration | 4724240 |
Madrid International Filings
Entry Number
1
Reference Number
A0087873
Original Filing Date USPTO
2019-07-22
International Registration Number
1495459
International Registration Date
2019-07-22
International Status Code
407
International Renewal Date
2029-07-22
| Madrid History Events | ||
| Date | Code | Description |
| 2021-08-18 | CBMPP | CEASING OF EFFECT PROCESSED |
| 2021-08-18 | CBPSP | PARTIAL CEASING OF EFFECT NOTICE SENT TO IB |
| 2019-07-22 | NEWAP | NEW APPLICATION FOR IR RECEIVED |
| 2019-07-23 | MCERT | MANUALLY CERTIFIED |
| 2019-07-23 | APPST | IR CERTIFIED AND SENT TO IB |
| 2019-10-31 | CREAT | APPLICATION FOR IR REGISTERED BY IB |
| 2021-08-04 | CBPCP | PARTIAL CEASING OF EFFECT TO BE PROCESSED |
| 2021-09-19 | PCBNP | PARTIAL CEASING OF EFFECT PROCESSED BY IB |
| 2020-01-29 | IRRCV | IRREGULARITY RESPONSE RECEIVED FROM APPLICANT |
| 2020-02-18 | IRRRJ | RESPONSE TO IRREGULARITY REVIEWED AND REJECTED |
Entry Number
2
Reference Number
A0088432
Original Filing Date USPTO
2019-08-07
International Registration Number
1499457
International Registration Date
2019-08-07
International Status Code
480
International Renewal Date
2029-08-07
| Madrid History Events | ||
| Date | Code | Description |
| 2021-08-18 | CBMPP | CEASING OF EFFECT PROCESSED |
| 2021-08-18 | CBPSP | PARTIAL CEASING OF EFFECT NOTICE SENT TO IB |
| 2019-10-18 | IRRCV | IRREGULARITY RESPONSE RECEIVED FROM APPLICANT |
| 2019-09-23 | IRREG | IRREGULARITY NOTICE RECEIVED FROM IB |
| 2021-08-04 | CBPCP | PARTIAL CEASING OF EFFECT TO BE PROCESSED |
| 2020-09-04 | PEXNX | SUBSEQUENT DESIGNATION PROCESSED BY IB |
| 2021-09-19 | PCBNP | PARTIAL CEASING OF EFFECT PROCESSED BY IB |
| 2020-08-06 | SDRCV | SUBSEQUENT DESIGNATION RECEIVED |
| 2020-08-06 | SDSNT | SUBSEQUENT DESIGNATION SENT TO IB |
| 2019-11-21 | CREAT | APPLICATION FOR IR REGISTERED BY IB |
| 2019-10-24 | IRRAC | RESPONSE TO IRREGULARITY REVIEWED AND ACCEPTED |
| 2019-10-24 | IRSNT | IRREGULARITY RESPONSE SENT TO IB |
| 2019-08-07 | ACERT | AUTOMATICALLY CERTIFIED |
| 2019-08-07 | NEWAP | NEW APPLICATION FOR IR RECEIVED |
| 2019-08-07 | APPST | IR CERTIFIED AND SENT TO IB |
Trademark Events
| Event Date | Event Description |
| 2019-07-18 | NEW APPLICATION ENTERED IN TRAM |
| 2019-07-18 | TEAS VOLUNTARY AMENDMENT RECEIVED |
| 2019-07-18 | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED |
| 2019-07-19 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| 2019-09-30 | ASSIGNED TO EXAMINER |
| 2019-10-03 | NON-FINAL ACTION WRITTEN |
| 2019-10-03 | NON-FINAL ACTION E-MAILED |
| 2019-10-03 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 2020-01-13 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2020-01-13 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2020-01-13 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2020-01-14 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 2020-01-17 | ASSIGNED TO LIE |
| 2020-02-05 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 2020-02-25 | PUBLISHED FOR OPPOSITION |
| 2020-02-25 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 2020-04-21 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 2020-10-20 | TEAS EXTENSION RECEIVED |
| 2020-10-20 | EXTENSION 1 FILED |
| 2020-10-20 | EXTENSION 1 GRANTED |
| 2020-10-22 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 2021-03-01 | TEAS STATEMENT OF USE RECEIVED |
| 2021-03-19 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 2021-03-01 | USE AMENDMENT FILED |
| 2021-03-19 | STATEMENT OF USE PROCESSING COMPLETE |
| 2021-04-01 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 2021-04-02 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 2021-05-04 | REGISTERED-PRINCIPAL REGISTER |
